期刊
PROTEIN & CELL
卷 -, 期 -, 页码 -出版社
OXFORD UNIV PRESS
DOI: 10.1093/procel/pwad052
关键词
microbiome; cancer; diagnosis; prognosis; therapy
类别
The profound influence of microbiota in cancer initiation and progression has led to extensive research on cancer microbiome and its clinical relevance. Microbiota can serve as effective diagnostic and prognostic biomarkers, and their relationship with the therapeutic efficacy, toxicity, or side effects of cancer treatments has been highlighted.
The profound influence of microbiota in cancer initiation and progression has been under the spotlight for years, leading to numerous researches on cancer microbiome entering clinical evaluation. As promising biomarkers and therapeutic targets, the critical involvement of microbiota in cancer clinical practice has been increasingly appreciated. Here, recent progress in this field is reviewed. We describe the potential of tumor-associated microbiota as effective diagnostic and prognostic biomarkers, respectively. In addition, we highlight the relationship between microbiota and the therapeutic efficacy, toxicity, or side effects of commonly utilized treatments for cancer, including chemotherapy, radiotherapy, and immunotherapy. Given that microbial factors influence the cancer treatment outcome, we further summarize some dominating microbial interventions and discuss the hidden risks of these strategies. This review aims to provide an overview of the applications and advancements of microbes in cancer clinical relevance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据